Home Medical Comms 3D experimental system to evaluate candidate drugs against glioma

3D experimental system to evaluate candidate drugs against glioma

by Newsroom


A three-dimensional experimental system has been developed to study the response to drugs in low-grade glioma, a tumor of the central nervous system that often occurs in children. The project, developed by the University of Trento, Bambino Gesù Children’s Hospital and Sapienza University of Rome, is a breakthrough in the study, understanding and treatment of the disease. The results have been published in the international journal Molecular Cancer.


Glioma is a tumor of the central nervous system that originates from glial cells, which support neurons in the brain. In the less aggressive, slow-progressing forms, gliomas are often found in…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC